Novel pharmacotherapeutic options for the treatment of postural orthostatic tachycardia syndrome

Anthony Lyonga Ngonge,Christabel Nyange,Jalal K Ghali,Jalal K. Ghali
DOI: https://doi.org/10.1080/14656566.2024.2319224
2024-03-12
Expert Opinion on Pharmacotherapy
Abstract:Introduction Postural tachycardia syndrome (POTS) is a disorder characterized by a constellation of symptoms including lightheadedness, fatigue, and palpitations when upright, associated with an increase in the heart rate (HR) of > 30 beats per minute when changing from a lying down to standing position or head-up tilt position and not associated with orthostatic hypotension. The causes as well as the management of POTS are not quite fully understood.
pharmacology & pharmacy
What problem does this paper attempt to address?